TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Merck Life Science AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
118,864
|
90,862
|
74,331 |
Financial expenses |
110
|
3
|
7 |
Earnings before taxes |
63,894
|
60,352
|
47,209 |
EBITDA |
63,562
|
60,344
|
47,212 |
Total assets |
82,458
|
56,427
|
60,388 |
Current assets |
81,129
|
49,029
|
53,420 |
Current liabilities |
11,963
|
6,596
|
6,711 |
Equity capital |
69,524
|
49,243
|
53,508 |
- share capital |
926
|
1,007
|
1,026 |
Employees (average) |
46
|
29
![]() |
29 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
84.3%
|
87.3%
|
88.6% |
Turnover per employee |
2,584
|
3,133
|
2,563 |
Profit as a percentage of turnover |
53.8%
|
66.4%
|
63.5% |
Return on assets (ROA) |
77.6%
|
107.0%
|
78.2% |
Current ratio |
678.2%
|
743.3%
|
796.0% |
Return on equity (ROE) |
91.9%
|
122.6%
|
88.2% |
Change turnover |
35,362
|
17,908
|
5,550 |
Change turnover % |
42%
|
25%
|
8% |
Chg. No. of employees |
17
|
0
|
1 |
Chg. No. of employees % |
59%
|
0%
|
4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.